FDA Approved: TYBLUME — Original Application (Exeltis USA, Inc.)

View source ↗

Summary

FDA approves TYBLUME, a new combination oral contraceptive containing levonorgestrel and ethinyl estradiol, under the original application from Exeltis USA, Inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• TYBLUME (levonorgestrel and ethinyl estradiol)

Snippet

ORIG AP for TYBLUME (LEVONORGESTREL AND ETHINYL ESTRADIOL)